Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient.

Yates SW.

Int J Gen Med. 2013 Mar 21;6:167-80. doi: 10.2147/IJGM.S39379. Print 2013.

2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
3.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
4.

Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.

Deitelzweig S.

Cardiovasc Ther. 2014 Apr;32(2):74-81. doi: 10.1111/1755-5922.12048. Review.

PMID:
24119252
5.
6.

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J.

J Med Econ. 2012;15(4):776-85. doi: 10.3111/13696998.2012.680555. Epub 2012 Apr 13.

PMID:
22449118
7.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
8.

Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation.

Xiong Q, Lip GY.

Curr Treat Options Neurol. 2015 Feb;17(2):331. doi: 10.1007/s11940-014-0331-4.

PMID:
25665980
9.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
10.

Novel oral anticoagulants for atrial fibrillation.

Hankey GJ, Eikelboom JW.

Curr Atheroscler Rep. 2013 Aug;15(8):344. doi: 10.1007/s11883-013-0344-6. Review.

PMID:
23761015
11.

Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.

Stöllberger C, Finsterer J.

Herz. 2015 Apr;40 Suppl 2:140-5. doi: 10.1007/s00059-014-4188-9. Epub 2015 Jan 25. Review.

PMID:
25616425
12.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
13.

Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis.

Lin L, Lim WS, Zhou HJ, Khoo AL, Tan KT, Chew AP, Foo D, Chin JJ, Lim BP.

J Am Med Dir Assoc. 2015 Dec;16(12):1103.e1-19. doi: 10.1016/j.jamda.2015.09.008. Epub 2015 Oct 31. Review.

PMID:
26527225
14.

New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons.

Sardar P, Chatterjee S, Wu WC, Lichstein E, Ghosh J, Aikat S, Mukherjee D.

PLoS One. 2013 Oct 25;8(10):e77694. doi: 10.1371/journal.pone.0077694. eCollection 2013.

15.

Beyond warfarin: a patient-centered approach to selecting novel oral anticoagulants for stroke prevention in atrial fibrillation.

Patel KK, Mehdirad AA, Lim MJ, Ferreira SW, Mikolajczak PC, Stolker JM.

J Hosp Med. 2014 Jun;9(6):400-6. doi: 10.1002/jhm.2201. Epub 2014 Apr 9. Review.

PMID:
24715600
16.

The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis.

Mitchell SA, Simon TA, Raza S, Jakouloff D, Orme ME, Lockhart I, Drost P.

Clin Appl Thromb Hemost. 2013 Nov-Dec;19(6):619-31. doi: 10.1177/1076029613486539. Epub 2013 May 22. Review.

PMID:
23698729
17.

Novel anticoagulants in atrial fibrillation stroke prevention.

Norgard NB, Dinicolantonio JJ, Topping TJ, Wee B.

Ther Adv Chronic Dis. 2012 May;3(3):123-36. doi: 10.1177/2040622312438934.

18.

An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation.

Deedwania P, Huang GW.

Core Evid. 2012;7:49-59. doi: 10.2147/CE.S25637. Epub 2012 Jul 9.

19.

Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants.

Morais J, De Caterina R.

Cardiovasc Drugs Ther. 2016 Apr;30(2):201-14. doi: 10.1007/s10557-015-6632-3.

20.

New advances in the treatment of atrial fibrillation: focus on stroke prevention.

Lau YC, Lip GY.

Expert Opin Pharmacother. 2014 Oct;15(15):2193-204. doi: 10.1517/14656566.2014.948418. Epub 2014 Aug 12. Review.

PMID:
25112657
Items per page

Supplemental Content

Write to the Help Desk